ACCC blocks ACL’s proposed $1.5B Healius takeover, as offer taken off table
Blood vials, pathology
Corporate 2023-12-15 10:30 am By Christine Caulfield
Please login to bookmark Close

Despite proposing a divestiture as part of its planned takeover of Healius, Australian Clinical Labs has failed to win the approval of the competition regulator for the $1.5 billion deal.

Subscribe to Lawyerly to access this article.

Already a subscriber?
Lost your password?
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au